‘Don’t Be Afraid’: Exploring the Rare Tumor Type TGCT

Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained.

Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained.

TGCT is a non-malignant tumor, but one expert explained how it can similarly affect patients.

One expert explains the importance of a multidisciplinary care team for patients with TGCT.

Patients with TGCT are encouraged to honestly discuss their pain with their care teams.